Related Experiment Video
Updated: Jul 2, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
[Prevention of left ventricular remodeling after myocardial infarction: efficacy of physical training]
Camillo Taglieri1, Enrico Lombardo, Mauro Feola
1Riabilitazione Cardiologica, Ospedale SS Trinità Fossano, Italy.
Insights
Preventing cardiac remodelling after myocardial infarction is crucial for patient prognosis. Therapies like ACE-inhibitors, beta-blockers, and aerobic training show efficacy in improving heart function and reducing adverse remodelling.
Area of Science:
- Cardiology
- Cardiovascular Research
- Medical Science
Context:
- Post-myocardial infarction (MI) left ventricular (LV) remodelling significantly impacts prognosis.
- Therapies aim to prevent the progression of LV dysfunction to refractory heart failure post-MI.
Purpose:
- To review therapeutic strategies for preventing post-MI cardiac remodelling.
- To evaluate the efficacy of various treatments, including pharmacological agents and exercise interventions.
Summary:
- ACE-inhibitors and beta-blockers are proven effective in managing post-MI remodelling.
- Angiotensin receptor blockers (ARBs) like losartan and valsartan show comparable safety and efficacy to ACE-inhibitors.
- Spironolactone offers benefits but carries a risk of hyperkalemia.
- Aerobic physical training enhances left ventricular ejection fraction and reduces LV enlargement post-MI, potentially via neurohormonal, microcirculatory, and endothelial improvements.
Impact:
- Effective management of post-MI remodelling can improve patient outcomes and reduce heart failure progression.
- Aerobic training presents a non-pharmacological approach to mitigate adverse cardiac remodelling.
- Understanding these therapeutic targets is vital for optimizing patient care following acute myocardial infarction.
Abstract:
Post-myocardial infarction left ventricular remodelling should be considered an important therapeutic target in patients after an acute myocardial infarction, considering the heavy prognostic implication. The therapies used in these patients should reduce the progression of the left ventricular dysfunction to refractory heart failure. In order to prevent post-myocardial infarction cardiac remodelling, different therapies have been tested, and for ACE-inhibitors and beta-blockers a clear demonstration of efficacy has been obtained. Losartan and valsartan, two widely used angiotensin receptor blockers, demonstrated to be safe and equally useful compared to ACEI. The addition of spironolactone to the standard therapy for heart failure has a clear beneficial effect but the clinical use has been refrained by the risk of iperkaliemia. Aerobic physical training improves the left ventricular ejection fraction in patients with systolic dysfunction, reducing the progressive enlargement after myocardial infarction. The positive effect of aerobic training on cardiac remodelling might be related to the positive effect on neurhormonal assessment, to he improvement of microcirculatory myocardial perfusion and of endothelial function.
More Related Videos
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiomyopathy V: Interprofessional Care
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be met...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis III: Medical Management
Aortic Regurgitation III: Medical Management